how glp 1 drugs work Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 Drugs for Weight Loss

Department of Health and Human Services Obesity: Health Consequences of Being Overweight. World Health Organization Obesity and Cancer Fact Sheet. National Cancer Institute, U.S

475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed

While the overall number of affected patients was small (0.2% versus 0.1%), the difference was statistically significant

It's not uncommon, for example, to see some weight loss drugs negatively impact blood pressure and hypertension

Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression